SAGICO and its principals have achieved global success across more than 60 countries. The company operates through a privately held global network with an active pipeline of innovative products and ...
Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR™ Peptide Enhanced Bone Graft in ...
Peer-reviewed results from the two-level multi-center FDA Investigational Device Exemption study reiterate disc's superiority to ACDF The peer-reviewed publication reiterates that the Simplify Disc ...
SAGICO'S CLINICAL OUTCOMES-BASED STUDIES At SAGICO, we contribute meaningful, data-driven insights that support ...
The trend towards ambulatory surgery for procedures previously limited to the inpatient setting is well established. [6,7,8,9,10,11] Trends in spinal surgery towards less invasive approaches and ...
Despite being one of the most common spinal surgeries, anterior cervical discectomy and fusion, a type of treatment for forms of degenerative disc disease, is a major procedure that sometimes fails in ...
Please provide your email address to receive an email when new articles are posted on . An artificial cervical disc improved clinical outcomes vs. anterior cervical discectomy and fusion at 5-year ...
SeaSpine Holdings Corporation SPNE announced the complete commercial launch of its Admiral ACP System for anterior cervical discectomy and fusion (ACDF) procedures. Admiral ACP features the next ...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the first patient implant in a U.S. Food ...
With more than 100,000 implantations worldwide, the M6-C and M6-L discs continue to demonstrate strong clinical performance, safety and patient benefits LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results